Product Images Megestrol Acetate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Megestrol Acetate NDC 70954-896 by Ani Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label-1 - 240ml
This is a description of Megestrol Acetate Oral Suspension, USP, with a concentration of 40 mg/mL. It is recommended to shake well before dosing. Each mL contains 40 mg of micronized megestrol acetate in a lemon-lime flavored oral suspension. The package insert provides information on indications and dosage. It should be stored at room temperature and dispensed in a tight container away from heat. The medication should be kept out of the reach of children. Distributed by AN Pharmaceuticals, Inc. at Baudette, MN. Issue date: 12/7/2024. Batch number: LB4G34-00.*
Label-2 - 480ml
This is a description of Megestrol Acetate oral suspension, USP, with a concentration of 40 mg/mL. It is recommended to shake well before dosing, and each mL contains 40 mg of micronized megestrol acetate in lemon-lime flavored oral suspension. The packaging insert should be consulted for indications and dosage schedule. The medication should be stored at 20°C to 25°C (68°F to 77°F) in a controlled room temperature environment. It should be dispensed in a tight container and protected from heat, kept out of reach of children. This product is distributed by ANI Pharmaceuticals Inc. in Baudette, MN 56623. The issue date is 02/2024.*
Graph - graph
Image 1 - image 1
This is not a readable text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
